C4 Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in C4 Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $2.0M | 353k | 5.65 |
| 2023-09-30 | $778k | 418k | 1.86 |
| 2023-06-30 | $1.9M | 703k | 2.75 |
| 2023-03-31 | $1.8M | 559k | 3.14 |
| 2022-12-31 | $2.3M | 393k | 5.90 |
| 2022-06-30 | $296k | 39k | 7.55 |
| 2022-03-31 | $3.5M | 143k | 24.26 |
| 2021-12-31 | $5.8M | 181k | 32.20 |
| 2021-09-30 | $2.1M | 47k | 44.68 |
| 2021-06-30 | $5.0M | 133k | 37.83 |
| 2021-03-31 | $749k | 20k | 37.00 |
| 2020-12-31 | $3.4M | 104k | 33.13 |